Entrada Therapeutics Inc 2025年季度报告

FORM 10-Q____________________________ (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period from ____________ to ____________Commission File Number: 001-40969____________________________ ENTRADA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)____________________________ 81-3983399 (I.R.S. EmployerIdentification Number) (State or other jurisdiction ofincorporation or organization) Registrant’s telephone number, including area code: (857) 520-9158 Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered The Nasdaq Global Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Actof 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subjectto such filing requirements for the past 90 days. YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files). YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and“emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. TABLE OF CONTENTS Page Part IFinancial InformationItem 1.Financial Statements (Unaudited)8Condensed Consolidated Balance Sheets8Condensed Consolidated Statements of Operations and Comprehensive Income(Loss)9Condensed Consolidated Statements of Stockholders’ Equity10Condensed Consolidated Statements of Cash Flows11Notes to Condensed Consolidated Financial Statements12Item 2.Management’s Discussion and Analysis of Financial Condition and Results ofOperations23Item 3.Quantitative and Qualitative Disclosures about Market Risk32Item 4.Controls and Procedures33Part IIOther InformationItem 1.Legal Proceedings34Item 1A.Risk Factors34Item 2.Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchasesof Equity96Item 3.Defaults Upon Senior Securities96Item 4.Mine Safety Disclosures96Item 5.Other Information96Item 6.Exhibits98Signatures99 We own various U.S. federal trademark applications and unregistered trademarks, including our companyname and logo, that we use in connection with the operation of our business. This Quarterly Report on Form 10-Q("Quarterly Report") may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks, trade names orproducts in this Quarterly Report is not intended to, and does not imply a relationship with, or endorsement orsponsorship by us. Solely for convenience, the trademarks, service marks and trade names referred to in thisQuarterly Report may appear without the ®, TM or SM symbols, but the omission of such references is not intendedto indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that theapplicable owner of these trademarks, service marks and trade names will not assert, to the fullest extent underapplicable law, its rights. From time to time, we may use our website or our LinkedIn profile atwww.linkedin.com/company/entradatx to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors Relations section of our website, available atwww.entradatx.com. Investors are encouraged to review the Investors Relations section of our website because wemay post material information on that site that is not otherwise disseminated by us. Information that is contained inand can be accessed through our website or our LinkedIn profile is not incorporated into, and does not form a partof, this Quarterly Report. Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis Quarterly Report on Form 10-Q (“Quarterly Report”) contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the SecuritiesAct of 1933, as amended (the “Securities Act”), and Section 21E of the Securi